June 24, 2015
Today, the Senate Committee on Veterans’ Affairs held a hearing on
several bills addressing benefits for veterans, including S. 469, the
Women’s Veterans and Families Health Services Act of 2015. ASRM was
invited to comment on the bill and submitted a letter of support.
May 22, 2015
This week, ASRM and ACOG jointly submitted a comment letter to the
Institute of Medicine (IOM) regarding the potential usefulness of
mitochondrial transfer techniques that can be integrated into assisted
reproductive technology. The IOM is examining these therapies and the
amount and level of further study that the therapies require before
being offered routinely to patients. This week, at its third meeting on
the topic, the IOM heard public comments.
May 19, 2015
Statement attributable to ASRM President Rebecca Z. Sokol, MD, MPH “We are thrilled to see the introduction of HR 2257. With introduction of this bill, Chairman Miller has made a vital step towards assuring our country lives up to its obligation to do its best to make our service members whole upon their return. For far too long, veterans whose service related injuries have left them unable to have children have not been able to access the best treatment available - In Vitro Fertilization. In fact, federal law currently bans the Department of Veterans Affairs from providing this care. Currently, active duty service members with certain classes of injuries have access to care that includes in vitro fertilization, while those who separate from service and enter the Department of VA health care system do not. This bill would rectify that inequity and address the reproductive health care needs of veterans that arose due to their service.”
April 30, 2015
Infertility patients and those who care for them may be interested in
attending this event taking place at Busboys and Poets at 5th and K
Streets, NW, Washington, DC on Friday, May 15, 2015 from 3 to 7 pm. The
traveling exhibit incorporates visual art and written expression about
infertility, reflecting the diversity of experience of people whose
lives it has affected: the newly diagnosed, patients in treatment,
families and individuals trying to adopt, parents whose infertility has
been resolved, and those who remain childfree.
April 17, 2015
National Infertility Awareness Week is April 19 to 25 and ASRM is participating in a Twitter Chat on Infertility. For an hour, representatives from six diverse organizations with expertise in infertility will be tweeting the facts about the condition and answering questions like: What is infertility? How is it treated? How is infertility misunderstood? How does the infertility affect the lives of patients?
April 16, 2015
Please join RESOLVE: The National Infertility Association and ASRM President Dr. Rebecca Sokol, for RESOLVE’s annual Advocacy Day event on May 14, 2015 in Washington, DC. RESOLVE’s Advocacy Day brings infertility patients and professionals together to advocate on Capitol Hill for legislation important to our community.
April 15, 2015
The problematic SGR formula that has threatened payment reductions for doctors for many years is at long last set to be repealed. Late last night, the Senate voted to pass HR 2, the Medicare Access and Chip Reauthorization Act. The Senate bill is identical to the version that passed the House of Representatives in late March. The President is expected to sign the legislation into law. The Senate vote occurred just hours before an automatic 21% cut in Medicare fees was scheduled to take effect.
April 14, 2015
ASRM has added five more tests and treatments to its list of procedures infertility patients and their doctors need to consider carefully.
April 14, 2015
The American Society for Reproductive Medicine (ASRM) today announced it was endorsing the statement released from the International Society for Stem Cell Research (ISSCR) calling for a moratorium on human clinical uses of Germ-Line Gene Editing until the safety and efficacy of the technique can be assessed.
March 30, 2015
The American Society for Reproductive Medicine, America’s leading professional organization in reproductive medicine and infertility, and VirtaMmed, the world’s leader in building customized virtual reality simulation devices for medicine, are pleased to announce the development of a simulator for training in ultrasound -guided and -–unguided embryo transfer in In Vitro Fertilization (IVF) and in Intrauterine Insemination (IUI).